Suppr超能文献

术前球蛋白与白蛋白比值是一种基于炎症的新型预后系统,可预测肝细胞癌患者行潜在根治性肝切除术后的生存率。

The preoperative globulin-to-albumin ratio, a novel inflammation-based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma.

作者信息

Shimizu Takayuki, Ishizuka Mitsuru, Suzuki Takashi, Tanaka Genki, Park Kyung Hwa, Matsumoto Takatsugu, Shiraki Takayuki, Sakuraoka Yuhki, Kato Masato, Aoki Taku, Kubota Keiichi

机构信息

Second Department of Surgery, Dokkyo Medical University, Tochigi, Japan.

出版信息

J Surg Oncol. 2017 Dec;116(8):1166-1175. doi: 10.1002/jso.24772. Epub 2017 Aug 29.

Abstract

BACKGROUND AND OBJECTIVES

Although the globulin-to-albumin ratio (GAR) is useful for prognostication of patients with various cancers, its relationship with hepatocellular carcinoma (HCC) remains unclear. The study aims to investigate the relationship between GAR and postoperative survival among patients with HCC undergoing potentially curative liver resection (LR).

METHODS

We retrospectively reviewed 368 patients with newly diagnosed HCC who underwent initial and potentially curative LR. Univariate and multivariate analyses using the Cox proportional hazard model were performed to detect clinical characteristics that correlated with overall survival (OS). Kaplan-Meier analysis and log-rank test were used to compare OS and disease-free survival (DFS).

RESULTS

The result of multivariate analysis using 25 clinical characteristics selected by univariate analysis revealed that the GAR (≥0.918/<0.918) was significantly associated with OS (hazard ratio [HR], 2.398; 95% confidence interval [CI], 1.012-5.683; P = 0.047), as well as platelet count (<14/≥14, ×10 /mm ) and portal vein invasion (presence/absence). Kaplan-Meier analysis and log-rank test demonstrated that the OS and DFS of patients with a high GAR (>0.918) were significantly worse than that of patients with a low GAR (≤0.918).

CONCLUSIONS

The GAR is a useful predictor of postoperative survival among patients with HCC undergoing potentially curative LR.

摘要

背景与目的

尽管球蛋白与白蛋白比值(GAR)对多种癌症患者的预后评估有帮助,但其与肝细胞癌(HCC)的关系仍不明确。本研究旨在探讨GAR与接受潜在根治性肝切除术(LR)的HCC患者术后生存之间的关系。

方法

我们回顾性分析了368例新诊断为HCC并接受初次潜在根治性LR的患者。采用Cox比例风险模型进行单因素和多因素分析,以检测与总生存(OS)相关的临床特征。采用Kaplan-Meier分析和对数秩检验比较OS和无病生存(DFS)。

结果

对单因素分析筛选出的25个临床特征进行多因素分析的结果显示,GAR(≥0.918/<0.918)与OS显著相关(风险比[HR],2.398;95%置信区间[CI],1.012 - 5.683;P = 0.047),血小板计数(<14/≥14,×10⁹/mm³)和门静脉侵犯(存在/不存在)也与之相关。Kaplan-Meier分析和对数秩检验表明,GAR高(>0.918)的患者的OS和DFS显著低于GAR低(≤0.918)的患者。

结论

GAR是接受潜在根治性LR的HCC患者术后生存的有用预测指标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验